Literature DB >> 12588010

Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive ethiopians.

D Wolday1, B Hailu, M Girma, E Hailu, E Sanders, A L Fontanet.   

Abstract

SETTING: Prospective cohort study, Ethiopia.
OBJECTIVE: To study changes in biological markers of HIV infection progression before and after development of TB disease.
DESIGN: A longitudinal study of 804 adult factory workers (95 HIV-positive, 709 HIV-negative), who were followed every 6 months for a median of 3.8 years.
RESULTS: Overall, the incidence rate of TB was 10/ 222 = 45.1 (95%CI 24.3-83.9) per 1000 person-years of observation (PYO) among HIV-1-positive participants, compared to 14/2,054 = 6.8 (95%CI 4.0-11.5) per 1,000 PYO among HIV-1-negative participants (incidence rate ratio 6.62, 95%CI 2.94-14.9). Among the 10 HIV-positive participants who subsequently developed TB disease, the CD4 count was low (median 201/microl, range 45-419), and viral load high (median 4.97 log copies/ml, range 3.70-5.58), at the routine follow-up visit prior to TB diagnosis. Following TB treatment, plasma viral load remained persistently elevated despite clinical resolution of TB disease, and seven of the 10 patients died within a median time of 8 months.
CONCLUSION: In this cohort, HIV-infected Ethiopians who developed TB disease already had low CD4 counts and high viral load prior to the diagnosis of TB. Viral load did not decrease following TB treatment, leading to a poor overall prognosis in these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588010

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia.

Authors:  Belete Tegbaru; Dawit Wolday; Tsehaynesh Messele; Mengistu Legesse; Yared Mekonnen; Frank Miedema; Debbie van Baarle
Journal:  Clin Vaccine Immunol       Date:  2006-07

2.  Prospective study of immunomodulation in osteoarticular tuberculosis non responsive to anti tubercular therapy.

Authors:  B P Sharma; Amit Kumar; Saubhik Das; Shambhu Prasad
Journal:  J Clin Orthop Trauma       Date:  2017-07-03

Review 3.  HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes.

Authors:  Wim Delva; Jeffrey W Eaton; Fei Meng; Christophe Fraser; Richard G White; Peter Vickerman; Marie-Claude Boily; Timothy B Hallett
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

4.  Plasmodium falciparum Infection Does Not Affect Human Immunodeficiency Virus Viral Load in Coinfected Rwandan Adults.

Authors:  Krishanthi Subramaniam; Rebeca M Plank; Nina Lin; Adam Goldman-Yassen; Emil Ivan; Carlos Becerril; Kimdar Kemal; Moonseong Heo; Marla J Keller; Eugene Mutimura; Kathryn Anastos; Johanna P Daily
Journal:  Open Forum Infect Dis       Date:  2014-08-21       Impact factor: 3.835

5.  CD4 count and tuberculosis risk in HIV-positive adults not on ART: a systematic review and meta-analysis.

Authors:  Penelope K Ellis; Willam J Martin; Peter J Dodd
Journal:  PeerJ       Date:  2017-12-14       Impact factor: 2.984

6.  Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.

Authors:  Dawit Wolday; Yazezew Kebede; Dorsisa Legesse; Dawd S Siraj; Joseph A McBride; Mitchell J Kirsch; Robert Striker
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240

7.  Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study.

Authors:  Kelemu Tilahun Kibret; Alemayehu Worku Yalew; Belaineh Girma Belaineh; Muluken Melese Asres
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

8.  Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.

Authors:  Abraham Miranda; Meade Morgan; Leda Jamal; Kayla Laserson; Draurio Barreira; Guida Silva; Joseney Santos; Charles Wells; Patricia Paine; Denise Garrett
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.